{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:47:19Z","timestamp":1781250439295,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UG3\/UH3 NS134920"],"award-info":[{"award-number":["UG3\/UH3 NS134920"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA035552"],"award-info":[{"award-number":["R01 DA035552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA056646"],"award-info":[{"award-number":["R01 DA056646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA032910"],"award-info":[{"award-number":["R01 DA032910"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA013930"],"award-info":[{"award-number":["R01 DA013930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01 DA051079"],"award-info":[{"award-number":["U01 DA051079"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U18 DA052319"],"award-info":[{"award-number":["U18 DA052319"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH2\/UH3 DA041115"],"award-info":[{"award-number":["UH2\/UH3 DA041115"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cbi.2025.111675","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:01:57Z","timestamp":1753974117000},"page":"111675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A cocaine hydrolase engineered from human butyrylcholinesterase as a medical countermeasure for aldicarb poisoning"],"prefix":"10.1016","volume":"420","author":[{"given":"Johnathan E.","family":"LeSaint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellore Bhanu","family":"Chandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Kyomuhangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-7269","authenticated-orcid":false,"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111675_bib1","series-title":"Encyclopedia of Toxicology","first-page":"64","article-title":"Aldicarb","author":"Harp","year":"2005"},{"key":"10.1016\/j.cbi.2025.111675_bib4","series-title":"Encyclopedia of Forensic Sciences","author":"Siegel","year":"2013"},{"key":"10.1016\/j.cbi.2025.111675_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.abb.2018.08.006","article-title":"Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size","volume":"655","author":"Venkatasubban","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2025.111675_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1191\/096032701718890612","article-title":"Repeated measurements of aldicarb in blood and urine in a case of nonfatal poisoning","volume":"20","author":"Tracqui","year":"2001","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cbi.2025.111675_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3109\/15563650.2015.1054504","article-title":"The pharmacokinetics and pharmacodynamics of severe aldicarb toxicity after overdose","volume":"53","author":"Michael","year":"2015","journal-title":"Clin. Toxicol."},{"issue":"7","key":"10.1016\/j.cbi.2025.111675_bib8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-020-02797-0","article-title":"Organophosphorus compounds and oximes: a critical review","volume":"94","author":"Worek","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111675_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101007","article-title":"Covalent inhibition of hAChE by organophosphates causes homodimer dissociation through long-range allosteric effects","volume":"297","author":"Blumenthal","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cbi.2025.111675_bib10","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1039\/C9RA08599H","article-title":"Recent developments on oximes to improve the blood brain barrier penetration for the treatment of organophosphorus poisoning: a review","volume":"10","author":"Norrrahim","year":"2020","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.cbi.2025.111675_bib11","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/slct.201601828","article-title":"\u03b2-Aminoalcohols as potential reactivators of aged Sarin-\/Soman-Inhibited acetylcholinesterase","volume":"2","author":"Khavrutskii","year":"2017","journal-title":"ChemistrySelect"},{"issue":"16","key":"10.1016\/j.cbi.2025.111675_bib12","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1021\/acs.jmedchem.7b01620","article-title":"Demonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents","volume":"61","author":"Zhuang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111675_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109996","article-title":"Strategies for developing a recombinant butyrylcholinesterase medical countermeasure for organophosphorus poisoning","volume":"363","author":"Allard","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111675_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111552","article-title":"Treatment of acute organophosphate poisoning by using a cocaine hydrolase engineered from human butyrylcholinesterase","volume":"416","author":"LeSaint","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111675_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2018.07.006","article-title":"Catalytic bioscavengers as countermeasures against organophosphate nerve agents","volume":"92","author":"Goldsmith","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111675_bib16","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/acs.biomac.0c00959","article-title":"Catalytic detoxification of organophosphorus nerve agents by butyrylcholinesterase-polymer-oxime bioscavengers","volume":"21","author":"Zhang","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cbi.2025.111675_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.976284","article-title":"Hapten designs based on aldicarb for the development of a colloidal gold immunochromatographic quantitative test strip","volume":"9","author":"Shen","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.cbi.2025.111675_bib18","article-title":"Atropine reduces aldicarb-induced sensitivity to C. elegans electroshock model","author":"Suthakaran","year":"2022","journal-title":"MicroPubl. Biol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111675_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1091581816638086","article-title":"Efficacy of recommended pre-hospital human equivalent doses of atropine and pralidoxime against the toxic effects of carbamate poisoning in the hartley Guinea pig","volume":"35","author":"Brittaina","year":"2016","journal-title":"Int. J. Toxicol."},{"issue":"4","key":"10.1016\/j.cbi.2025.111675_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13179","article-title":"Recovery of dopaminergic system after cocaine exposure and impact of a long-acting cocaine hydrolase","volume":"27","author":"Deng","year":"2022","journal-title":"Addict. Biol."},{"issue":"7","key":"10.1016\/j.cbi.2025.111675_bib21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/acs.bioconjchem.2c00210","article-title":"Development of a highly efficient long-acting cocaine hydrolase entity to accelerate cocaine metabolism","volume":"33","author":"Zheng","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.cbi.2025.111675_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108251","article-title":"Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: long-Lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine","volume":"176","author":"Zhang","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2025.111675_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1073\/pnas.1517713113","article-title":"Long-acting cocaine hydrolase for addiction therapy","volume":"113","author":"Chen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2025.111675_bib24","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/ncomms4457","article-title":"A highly efficient cocaine-detoxifying enzyme obtained by computational design","volume":"5","author":"Zheng","year":"2014","journal-title":"Nat. Commun."},{"issue":"36","key":"10.1016\/j.cbi.2025.111675_bib25","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1021\/ja803646t","article-title":"Most efficient cocaine hydrolase designed by virtual screening of transition states","volume":"130","author":"Zheng","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"10.1016\/j.cbi.2025.111675_bib26","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication","volume":"102","author":"Pan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.cbi.2025.111675_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cbi.2010.01.004","article-title":"Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine","volume":"187","author":"Yang","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111675_bib28","article-title":"Clinical potential of an enzyme-based novel therapy for cocaine overdose","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111675_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1208\/s12248-017-0167-4","article-title":"Effectiveness of a cocaine hydrolase for cocaine toxicity treatment in Male and female rats","volume":"20","author":"Zheng","year":"2018","journal-title":"AAPS J."},{"issue":"11","key":"10.1016\/j.cbi.2025.111675_bib30","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbi.2025.111675_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.450","article-title":"Pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects","volume":"55","author":"Cohen-Barak","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111675_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/JCP.0000000000000347","article-title":"Assessment of pharmacokinetic and pharmacodynamic interactions between albumin-fused mutated butyrylcholinesterase and intravenously administered cocaine in recreational cocaine users","volume":"35","author":"Shram","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2025.111675_bib33","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/522S53a","article-title":"Quest for the quitting pill","volume":"522","author":"Willyard","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111675_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2016.05.019","article-title":"Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence","volume":"166","author":"Gilgun-Sherki","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cbi.2025.111675_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drugalcdep.2018.01.033","article-title":"TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene","volume":"188","author":"Shemesh-Darvish","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cbi.2025.111675_bib36","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1021\/bi1011628","article-title":"Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency","volume":"49","author":"Zheng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2025.111675_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/mol.110.068494","article-title":"Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine","volume":"79","author":"Xue","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111675_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1208\/s12248-020-00442-3","article-title":"Structure-based design and discovery of a long-acting cocaine hydrolase mutant with improved binding affinity to neonatal Fc receptor for treatment of cocaine abuse","volume":"22","author":"Zheng","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.cbi.2025.111675_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cbi.2019.04.012","article-title":"Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression","volume":"306","author":"Chen","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111675_bib40","series-title":"Patent Appl. No. 17\/129,736: \u201cIncreased Polypeptide Production Yields of Butyrylcholinesterase Polypeptides for Therapeutic Use\u201d (Patent Application Filed on December 21, 2020)","author":"Zhan","year":"2020"},{"issue":"22","key":"10.1016\/j.cbi.2025.111675_bib41","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"issue":"42","key":"10.1016\/j.cbi.2025.111675_bib42","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2025.111675_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.cbi.2025.111675_bib44","unstructured":"Schr\u00f6dinger Release 2021-4: Maestro 13.0, Schr\u00f6dinger, LLC, New York, NY, 2021-2024."},{"key":"10.1016\/j.cbi.2025.111675_bib45","series-title":"AMBER 2020","author":"Case","year":"2020"},{"issue":"1","key":"10.1016\/j.cbi.2025.111675_bib46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.cbi.2025.111675_bib47","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2025.111675_bib48","series-title":"Gaussian 16, Revision A.03","author":"Frisch","year":"2016"},{"issue":"11","key":"10.1016\/j.cbi.2025.111675_bib49","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jcc.540161106","article-title":"Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins","volume":"16","author":"Piotr Cieplak","year":"1995","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2025.111675_bib50","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Klein","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.cbi.2025.111675_bib51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/toxsci\/kfj094","article-title":"Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon","volume":"90","author":"Rosenfeld","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"50","key":"10.1016\/j.cbi.2025.111675_bib52","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1021\/acs.jpcb.3c06392","article-title":"Human butyrylcholinesterase mutants for (-)-Cocaine hydrolysis: a correlation relationship between catalytic efficiency and total hydrogen bonding energy with an oxyanion hole","volume":"127","author":"Zheng","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.cbi.2025.111675_bib53","first-page":"35","article-title":"Effect of aldicarb pesticide on some electrical properties of rat tissues and muscle","volume":"26","author":"Mohamed","year":"2016","journal-title":"Rom. J. Biophys."},{"key":"10.1016\/j.cbi.2025.111675_bib54","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1432-1033.2004.04110.x","article-title":"Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine: volumetric study of wild-type and D70G mutant behaviour","volume":"271","author":"Masson","year":"2004","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.cbi.2025.111675_bib55","first-page":"19","article-title":"Kinetics of inhibition of two forms of acetylcholinesterase from Panagrellus redivivus by organophosphorus and carbamate compounds","volume":"15","author":"Mulder","year":"1992","journal-title":"Fundam. Appl. Nematol."},{"key":"10.1016\/j.cbi.2025.111675_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1289\/ehp.8772267","article-title":"The toxicologic effects of the carbamate insecticide aldicarb in mammals: a review","volume":"72","author":"Risher","year":"1987","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2025.111675_bib57","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.forsciint.2004.09.028","article-title":"Aldicarb poisoning: one case report","volume":"146S","author":"Proenc","year":"2004","journal-title":"Forensic Sci. Int."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725003059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725003059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:53:25Z","timestamp":1762113205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725003059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S0009279725003059"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111675","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cocaine hydrolase engineered from human butyrylcholinesterase as a medical countermeasure for aldicarb poisoning","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111675"}}